Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with traditional biology research to accelerate drug discovery, today announced ...

One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is ...

Scientists are making new discoveries every day, but many of them fall under the radar. Some of these findings are ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

Life is thought to have begun when RNA began replicating itself, and researchers have got close to achieving this in the lab ...

Presentations highlight cutting-edge research in mitochondrial and neurodegeneration medicine, neurodegeneration, ...

As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.

AMP-945 – discovered at the former Cancer Therapeutics Cooperative Research Centre – works by suppressing a bodily agent ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced that its Trial in Progress abstract has been ...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focuson advanced or metastatic ...